Circulating microRNAs as Early Biomarkers of Colon Cancer: A Nested Case-Control Study Within a Prospective Cohort.

Area of Science:

• Molecular epidemiology
• Biomarker discovery
• Gastrointestinal oncology

Background:

• Circulating microRNAs (miRNAs) are potential non-invasive biomarkers for cancer risk.
• The role of circulating miRNAs in early colon cancer development remains unclear.
• Understanding miRNA dynamics is crucial for developing early detection strategies.

Purpose of the Study:

• To investigate the association between pre-diagnostic serum miRNA levels and colon cancer incidence.
• To evaluate the potential of specific miRNAs (Let7, Mir21, Mir155, Mir181, Mir222, Mir145, Mir92, Mir20) as early colon cancer biomarkers.
• To assess the challenges in using circulating miRNAs for early cancer risk prediction.

Main Methods:

• Nested case-control study within the EPIC-Italy cohort.
• Quantification of eight candidate miRNAs in serum from 104 colon cancer cases and 104 matched controls using RT-qPCR.
• Logistic regression analysis adjusted for multiple confounding factors.

Main Results:

• Elevated levels of Let7 showed a borderline association with reduced colon cancer odds (OR=0.91, p=0.06).
• Mir222 also suggested a potential association with lower colon cancer odds (OR=0.75, p=0.05) in multivariate models.
• No significant associations were consistently observed after statistical correction, highlighting challenges with early-stage biomarker detection.

Conclusions:

• Circulating miRNAs may have limited utility as very early biomarkers for colon cancer, especially when detected years before diagnosis.
• The temporal dynamics of miRNA alterations require further investigation with larger cohorts and longitudinal sampling.
• Future research should integrate miRNA analysis with inflammatory and immune markers to refine risk-adapted screening strategies.